MCH ANALYSIS RESEARCHMain site ↗
Financials

Insurance Brokers

7 companies under coverage.

Coverage

Insurance Brokers


Equity Research

Aon PLC (AON)

BUY. 12-month probability-weighted target $320 (+17% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

AONEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +7.7%
Equity Research

Erie Indemnity Company (ERIE)

HOLD. 12-month probability-weighted target $241 (+8% vs spot). P/E Multiple explains 54% of Monte Carlo outcome variance.

ERIEEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +5.8%
Equity Research

Ryan Specialty Group Holdings Inc (RYAN)

HOLD. 12-month probability-weighted target $41 (+10% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

RYANEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -8.1%
Equity Research

Brown & Brown Inc (BRO)

HOLD. 12-month probability-weighted target $62 (-2% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

BROEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -10.0%
Equity Research

Marsh & McLennan Companies, Inc. (MRSH)

HOLD. 12-month probability-weighted target $170 (-3% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

MRSHEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -13.4%
Equity Research

Willis Towers Watson PLC (WTW)

HOLD. 12-month probability-weighted target $267 (-10% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

WTWEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -13.7%
Equity Research

Arthur J Gallagher & Co (AJG)

HOLD. 12-month probability-weighted target $216 (-7% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

AJGEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -15.2%
MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies